Breaking News Instant updates and real-time market news.

GLYC

GlycoMimetics

$4.39 /

+0.07 (+1.62%)

, PFE

Pfizer

$37.89 /

+0.07 (+0.19%)

11:39
02/11/20
02/11
11:39
02/11/20
11:39

Pfizer notifies GlycoMimetics of termination of license agreement

GlycoMimetics (GLYC) disclosed last night that it received written notice from Pfizer (PFE) of Pfizer's termination of the license agreement by and between the two companies, effective April 5, 2020. Upon termination, all rights and licenses granted to Pfizer under the agreement will terminate and Pfizer will return to GlycoMimetics the rights to develop and commercialize the products subject to the agreement, including rivipansel, and will grant the company a non-exclusive license to use the intellectual property developed by Pfizer in connection with its development of such products. GlycoMimetics said it "will work with Pfizer to effectuate any necessary transition activities regarding the subject matter of the License Agreement, and will be determining what, if any, next steps to take with respect to the rivipansel program after reviewing the Phase 3 data more completely." The company will not incur any termination penalties as a result of the termination of the agreement. Shares of GlycoMimetics are up 10c to $4.40 in late morning trading.

GLYC

GlycoMimetics

$4.39 /

+0.07 (+1.62%)

PFE

Pfizer

$37.89 /

+0.07 (+0.19%)

  • 11

    Feb

  • 13

    Feb

  • 13

    Feb

  • 24

    Feb

  • 06

    Mar

  • 13

    Mar

  • 06

    Apr

GLYC GlycoMimetics
$4.39 /

+0.07 (+1.62%)

12/10/19 Roth Capital
GlycoMimetics' uproleselan presentation 'very exciting,' says Roth Capital
11/21/19 Roth Capital
GlycoMimetics price target lowered to $9 from $12 at Roth Capital
11/21/19 Stifel
GlycoMimetics' delayed Phase 3 timeline doesn't impact LT thesis, says Stifel
11/14/19
Fly Intel: Top five analyst initiations
PFE Pfizer
$37.89 /

+0.07 (+0.19%)

02/06/20 Mizuho
Pfizer initiated with a Buy, $42 price target at Mizuho
02/05/20 Mizuho
Pfizer initiated with a Buy at Mizuho
01/29/20 Cantor Fitzgerald
Pfizer growth prospect concerns overblown, says Cantor Fitzgerald
01/14/20 Ladenburg
Axsome Therapeutics price target raised to $165 from $139 at Ladenburg

TODAY'S FREE FLY STORIES

Options
One new option listing and one option delisting on April 7th » 08:30
04/07/20
04/07
08:30
04/07/20
08:30

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
NorthWestern upgraded to Buy from Neutral at Sidoti » 08:29
04/07/20
04/07
08:29
04/07/20
08:29
NWE

NorthWestern

/

+

Sidoti analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Facebook price target lowered to $175 from $260 at Barclays » 08:29
04/07/20
04/07
08:29
04/07/20
08:29
FB

Facebook

$165.42 /

+11.23 (+7.28%)

Barclays analyst Ross…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Varonis price target lowered to $65 from $110 at Craig-Hallum » 08:28
04/07/20
04/07
08:28
04/07/20
08:28
VRNS

Varonis

$56.97 /

+3.96 (+7.47%)

Craig-Hallum analyst Chad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Gol Linhas sees Q1 EPS 10.1c, consensus 20c » 08:27
04/07/20
04/07
08:27
04/07/20
08:27
GOL

Gol Linhas

$3.80 /

+0.285 (+8.11%)

GOL Linhas Aereas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
WeWork files lawsuit challenging SoftBank's decision to terminate tender offer » 08:27
04/07/20
04/07
08:27
04/07/20
08:27
WE

We Company

$0.00 /

+ (+0.00%)

, SFTBF

Use SFTBY

$0.00 /

+ (+0.00%)

, SFTBY

SoftBank

$0.00 /

+ (+0.00%)

WeWork (WE) is suing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Pacira initiated with an Outperform at Northland » 08:26
04/07/20
04/07
08:26
04/07/20
08:26
PCRX

Pacira

$31.96 /

+1.18 (+3.83%)

Northland analyst Tim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Green Dot assumed with a Buy at Craig-Hallum » 08:26
04/07/20
04/07
08:26
04/07/20
08:26
GDOT

Green Dot

$23.41 /

+1.64 (+7.53%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Sunrun update 'impressive and reassuring,' says Barclays » 08:26
04/07/20
04/07
08:26
04/07/20
08:26
RUN

Sunrun

$10.00 /

+1.16 (+13.12%)

Barclays analyst Moses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Immunomedics obtains Fast Track designation for sacituzumab govitecan » 08:26
04/07/20
04/07
08:26
04/07/20
08:26
IMMU

Immunomedics

$18.77 /

+9.38 (+99.89%)

Immunomedics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
DJ Transportation Average: Pivot points » 08:25
04/07/20
04/07
08:25
04/07/20
08:25
$DJT

DJ Transportation Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Technical Analysis
DJ Utility Average: Pivot points » 08:25
04/07/20
04/07
08:25
04/07/20
08:25
$DJU

DJ Utility Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
Dow Jones Industrial Average: Pivot points » 08:25
04/07/20
04/07
08:25
04/07/20
08:25
DJX

Dow Jones Industrial Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Aaron's cut to Equal Weight at Stephens ahead of 'different' type of recession » 08:25
04/07/20
04/07
08:25
04/07/20
08:25
AAN

Aaron's

$22.19 /

+3.66 (+19.75%)

, RCII

Rent-A-Center

$14.52 /

+1.9 (+15.06%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Morphic Therapeutic appoints Marc Schegerin as CFO, COO » 08:24
04/07/20
04/07
08:24
04/07/20
08:24
MORF

Morphic Holding

$15.07 /

+1.54 (+11.38%)

Morphic Therapeutic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
iShares Transportation Average: Pivot points » 08:24
04/07/20
04/07
08:24
04/07/20
08:24
IYT

iShares Transportation Average

$140.45 /

+9.67 (+7.39%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
Technology Select Sector SPDR: Pivot points » 08:24
04/07/20
04/07
08:24
04/07/20
08:24
XLK

Technology Select Sector SPDR

$83.72 /

+6.65 (+8.63%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Initiation
Raytheon Technologies initiated with an Overweight at Melius Research » 08:24
04/07/20
04/07
08:24
04/07/20
08:24
RTX

Raytheon Technologies

$57.45 /

+7.575 (+15.19%)

Melius Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
Energy Select Sector SPDR: Pivot points » 08:24
04/07/20
04/07
08:24
04/07/20
08:24
XLE

Energy Select Sector SPDR

$31.37 /

+1.56 (+5.23%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points » 08:24
04/07/20
04/07
08:24
04/07/20
08:24
XLY

Consumer Discretionary Sector SPDR

$100.21 /

+7.74 (+8.37%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
S&P Select Materials SPDR: Pivot points » 08:23
04/07/20
04/07
08:23
04/07/20
08:23
XLB

S&P Select Materials SPDR

$45.79 /

+3.18 (+7.46%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Westamerica upgraded to Buy from Hold at Maxim » 08:23
04/07/20
04/07
08:23
04/07/20
08:23
WABC

Westamerica

/

+

Maxim analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Menlo Therapeutics price target lowered to $2 from $8 at Barclays » 08:23
04/07/20
04/07
08:23
04/07/20
08:23
MNLO

Menlo Therapeutics

$1.36 /

-1.25 (-47.89%)

Barclays analyst Balaji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
Utilities SPDR: Pivot points » 08:23
04/07/20
04/07
08:23
04/07/20
08:23
XLU

Utilities SPDR

$55.80 /

+4.06 (+7.85%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
Consumer Staples Sector SPDR: Pivot points » 08:23
04/07/20
04/07
08:23
04/07/20
08:23
XLP

Consumer Staples Sector SPDR

$57.39 /

+2.04 (+3.69%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.